Your search returned 12 results.

Results
	1.	CASE REPORT Postoperative Use of the NormaTec Pneumatic Compression Device in Vascular Anomalies. [electronic resource] by Talbot, Simon G Kerstein, David Jacobs, Laura F Upton, Joseph Producer: 20120823 In: Eplasty vol. 12 Availability: No items available. Save to lists Add to cart (remove)
	2.	Early-Onset Pulmonary Events Associated With Brigatinib Use in Advanced NSCLC. [electronic resource] by Ng, Terry L Narasimhan, Narayana Gupta, Neeraj Venkatakrishnan, Karthik Kerstein, David Camidge, D Ross Producer: 20210106 In: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer vol. 15 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	The Effect of a High-Fat Meal on the Pharmacokinetics of Brigatinib, an Oral Anaplastic Lymphoma Kinase Inhibitor, in Healthy Volunteers. [electronic resource] by Tugnait, Meera Gupta, Neeraj Hanley, Michael J Venkatakrishnan, Karthik Sonnichsen, Daryl Kerstein, David Dorer, David J Narasimhan, Narayana Producer: 20200727 In: Clinical pharmacology in drug development vol. 8 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Effects of Strong CYP2C8 or CYP3A Inhibition and CYP3A Induction on the Pharmacokinetics of Brigatinib, an Oral Anaplastic Lymphoma Kinase Inhibitor, in Healthy Volunteers. [electronic resource] by Tugnait, Meera Gupta, Neeraj Hanley, Michael J Sonnichsen, Daryl Kerstein, David Dorer, David J Venkatakrishnan, Karthik Narasimhan, Narayana Producer: 20210528 In: Clinical pharmacology in drug development vol. 9 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Patient-reported outcomes and quality of life in advanced ALK+ non-small-cell lung cancer trial of brigatinib (ALTA). [electronic resource] by Lenderking, William R Lin, Huamao Speck, Rebecca M Zhu, Yanyan Huang, Hui Huang, Joice Kerstein, David Langer, Corey J Producer: 20200128 In: Future oncology (London, England) vol. 15 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	Comparative efficacy of brigatinib versus ceritinib and alectinib in patients with crizotinib-refractory anaplastic lymphoma kinase-positive non-small cell lung cancer. [electronic resource] by Reckamp, Karen Lin, Huamao M Huang, Joice Proskorovsky, Irina Reichmann, William Krotneva, Stanimira Kerstein, David Huang, Hui Lee, Joseph Producer: 20200224 In: Current medical research and opinion vol. 35 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7.	Converting EORTC QLQ-C30 scores to utility scores in the brigatinib ALTA study. [electronic resource] by Kawata, Ariane K Lenderking, William R Eseyin, Olabimpe R Kerstein, David Huang, Joice Huang, Hui Zhang, Pingkuan Lin, Huamao M Producer: 20200210 In: Journal of medical economics vol. 22 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	8.	Activity and safety of brigatinib in ALK-rearranged non-small-cell lung cancer and other malignancies: a single-arm, open-label, phase 1/2 trial. [electronic resource] by Gettinger, Scott N Bazhenova, Lyudmila A Langer, Corey J Salgia, Ravi Gold, Kathryn A Rosell, Rafael Shaw, Alice T Weiss, Glen J Tugnait, Meera Narasimhan, Narayana I Dorer, David J Kerstein, David Rivera, Victor M Clackson, Timothy Haluska, Frank G Camidge, David Ross Producer: 20170529 In: The Lancet. Oncology vol. 17 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	9.	Exploratory Analysis of Brigatinib Activity in Patients With Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer and Brain Metastases in Two Clinical Trials. [electronic resource] by Camidge, D Ross Kim, Dong-Wan Tiseo, Marcello Langer, Corey J Ahn, Myung-Ju Shaw, Alice T Huber, Rudolf M Hochmair, Maximilian J Lee, Dae Ho Bazhenova, Lyudmila A Gold, Kathryn A Ou, Sai-Hong Ignatius West, Howard L Reichmann, William Haney, Jeff Clackson, Tim Kerstein, David Gettinger, Scott N Producer: 20190913 In: Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 36 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	10.	Brigatinib in Crizotinib-Refractory ALK+ NSCLC: 2-Year Follow-up on Systemic and Intracranial Outcomes in the Phase 2 ALTA Trial. [electronic resource] by Huber, Rudolf M Hansen, Karin H Paz-Ares Rodríguez, Luis West, Howard L Reckamp, Karen L Leighl, Natasha B Tiseo, Marcello Smit, Egbert F Kim, Dong-Wan Gettinger, Scott N Hochmair, Maximilian J Kim, Sang-We Langer, Corey J Ahn, Myung-Ju Kim, Edward S Kerstein, David Groen, Harry J M Camidge, D Ross Producer: 20210106 In: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer vol. 15 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	11.	Brigatinib in Patients With Crizotinib-Refractory Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer: A Randomized, Multicenter Phase II Trial. [electronic resource] by Kim, Dong-Wan Tiseo, Marcello Ahn, Myung-Ju Reckamp, Karen L Hansen, Karin Holmskov Kim, Sang-We Huber, Rudolf M West, Howard L Groen, Harry J M Hochmair, Maximilian J Leighl, Natasha B Gettinger, Scott N Langer, Corey J Paz-Ares Rodríguez, Luis G Smit, Egbert F Kim, Edward S Reichmann, William Haluska, Frank G Kerstein, David Camidge, D Ross Producer: 20170908 In: Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 35 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	12.	Brigatinib versus Crizotinib in ALK-Positive Non-Small-Cell Lung Cancer. [electronic resource] by Camidge, D Ross Kim, Hye Ryun Ahn, Myung-Ju Yang, James Chih-Hsin Han, Ji-Youn Lee, Jong-Seok Hochmair, Maximilian J Li, Jacky Yu-Chung Chang, Gee-Chen Lee, Ki Hyeong Gridelli, Cesare Delmonte, Angelo Garcia Campelo, Rosario Kim, Dong-Wan Bearz, Alessandra Griesinger, Frank Morabito, Alessandro Felip, Enriqueta Califano, Raffaele Ghosh, Sharmistha Spira, Alexander Gettinger, Scott N Tiseo, Marcello Gupta, Neeraj Haney, Jeff Kerstein, David Popat, Sanjay Producer: 20181211 In: The New England journal of medicine vol. 379 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)